Another Thrombotic Event Connected to COVID Vaccine
August 29, 2021
The Lancet, an international weekly
medical journal, reports that a new
syndrome of vaccine-induced immune thrombotic thrombocytopenia (VITT) has
emerged after vaccination for COVID. According to reports, cerebral venous
thrombosis (CVT) is the most common manifestation of VITT and certain CVT cases
have been determined as being vaccine-induced.
Data collected
earlier this year from 99 patients among 43 U.K. hospitals show that after four
patients were excluded because tests showed no definitive evidence of cerebral
venous thrombosis, 70 of the remaining 95 patients had VITT and 25 did not.
According to the study, death occurred more frequently in patients with
VITT-associated CVT as compared with the non-VITT control group.
After the
introduction of the AstraZeneca vaccine, five cases of severe VITT were
reported in Norway, with four of those cases being CVT, according to reports. A
similar condition was noted with the Johnson & Johnson vaccine and case
reports also associate two mRNA vaccines — Moderna and Pfizer —with
thrombocytopenia, only with slightly different symptoms.
SOURCE: The Lancet August 6, 2021